Sort
21,453 grants matching “tuberculosis”
Puerto Rico Tuberculosis Control Program - Tuberculosis Elimination and Laboratory Cooperative Agreement
$635,022Ricardo Torres · Puerto Rico Department Of Health · U52 · FY2015 · PS
Clinical Interventional Studies of HIV Reservoirs
$634,967Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Strategies for tuberculosis control in prisons
$634,909Jason Randolph Andrews · Stanford University · R01 · FY2025 · AI
Long Acting Injectable Depots for TB Therapy
$634,791Patrick S. Stayton · University Of Washington · R61 · FY2023 · AI
Innate Immune Responses Triggered by M. Tuberculosis
$634,453Jeffery S Cox · University Of California Berkeley · P01 · FY2013 · AI
Administrative Core
$634,424David Louis Horn · Boston Medical Center · U19 · FY2014 · AI
Vaccination Strategies for Primary and Latent Pulmonary TB
$634,143Alistair John Ramsay · Lsu Health Sciences Center · P01 · FY2007 · HL
Epidemiology of multidrug-resistant tuberculosis in Peru
$634,100Mercedes C Becerra · Harvard Medical School · R01 · FY2007 · AI
Mathematical modeling of Mycobacterium tuberculosis dissemination
$634,089Vitaly V. Ganusov · Texas Biomedical Research Institute · R01 · FY2024 · AI
Investigation of Indoor Solid Fuel and Kerosene Use as Tuberculosis Risk Factors
$633,941Michael N Bates · University Of California Berkeley · R01 · FY2011 · ES
Novel Reporter Phages to Detect Complex TB Drug Resistance and Persistence
$633,748Michelle H Larsen · Albert Einstein College Of Medicine, Inc · R01 · FY2017 · AI
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
$633,564Awewura Jacob Kwara · University Of Florida · R01 · FY2022 · HD
Analysis of Chemical Structures and Therapeutic Activity of Agents for HIV, TB, and HBV (CHEMDB)
$633,557Louise Sumner · Gryphon Scientific, Llc · N01 · FY2020 · AI
PK/PD Evaluation Resistance Development in Caseating Granuloma
$633,491William Ramses Bishai · Johns Hopkins University · R01 · FY2009 · AI
A longitudinal cohort study to evaluate cardiovascular risk factors and disease in Haiti
$633,425Margaret Leighton McNairy · Weill Medical Coll Of Cornell Univ · R01 · FY2019 · HL
Arsenic and immune response to influenza vaccination in pregnant women and newborns
$633,416Christopher D Heaney · Johns Hopkins University · R01 · FY2019 · ES
Clinical Studies
$633,267Megan B Murray · Harvard Medical School · U19 · FY2021 · AI
Implementation Research for Vulnerable Women in South Africa
$633,243Wendee M Wechsberg · Research Triangle Institute · R01 · FY2016 · AA
Engineered Antimicrobial Platform to Target Pulmonary Intracellular Infections
$633,062Patrick S. Stayton · University Of Washington · R01 · FY2022 · AI
Innovating anti-tuberculosis drug susceptibility testing with a novel and rapid non-culture based phenotypic test using MPT64 biomarker
$633,020Midori Kato-Maeda · University Of California, San Francisco · R01 · FY2024 · AI
Role of CD8 T cells in immunity to tuberculosis
$633,008University Of Illinois At Chicago · R01 · FY2005 · RR
INH-induced lysis of Mycobacterium tuberculosis
$632,955Yeshiva University · R21 · FY2003 · AI
Making Better Decisions: Policy Modeling for AIDS and Drug Abuse
$632,906Douglas K Owens · Stanford University · R01 · FY2017 · DA
Clinical Core
$632,901Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI
Epidemiology of SARS-CoV-2 in Low-income Countries.
$632,901Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2020 · AI